Gynecologic Cancer
From the Journals
Frailty screening should be routine in endometrial cancer surgery
Conference Coverage
Study supports lower starting dose of lenvatinib for endometrial cancer
A 14-mg dose was safer and just as effective as a 20-mg dose in a retrospective study.
Conference Coverage
Combo shows efficacy in platinum-resistant ovarian cancer
Ixabepilone plus bevacizumab improved outcomes, compared with ixabepilone alone.
From the Journals
Call to eradicate all types of HPV cancers, not just cervical
"I completely agree that our ultimate goal should be the elimination of all HPV-related cancers - but we will require gender-neutral vaccination...
Conference Coverage
Niraparib maintenance offers continued benefit in some with recurrent ovarian cancer
Benefits were seen in patients with germline BRCA mutations.
Conference Coverage
Biomarkers predict efficacy of DKN-01 in endometrial cancer
High levels of DKK1 expression and the presence of Wnt or PIK3CA activating mutations are associated with better outcomes.
Opinion
The significance of mismatch repair deficiency in endometrial cancer
Endometrial cancers can be tested for MMR-d by performing immunohistochemistry to look for loss of expression in the four most common MMR genes,...
Conference Coverage
Gynecologic cancer patients at risk of insurance loss, ‘catastrophic’ costs
The Affordable Care Act did not spare many gynecologic cancer patients from financial hardship.
Conference Coverage
Frail status may be better than age for predicting ovarian cancer outcomes
Conference Coverage
Cytoreduction in advanced ovarian cancer: ‘Keep the status quo’
Debulking surgery should be considered whenever feasible, according to researchers.
Conference Coverage
Study: Gynecologic cancer therapy does not increase COVID-19 risks